Finally, our data demonstrate an increased CXCL10 expression in macrophages over time in the lungs of infants with BPD vs non-BPD, offering CXCL10-CXCR3 as a potential target for inflammation-driven progression of BPD. Here, CXCL10 is linked to bronchopulmonary dysplasia.